| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 394.7K | $3.94M | - | |
| Other | 389.3K | $3.88M | - | |
| Other | 330.7K | $3.30M | - | |
| Other | 326.3K | $3.25M | - | |
| Other | 323.4K | $3.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2015 | Versant Venture Capital Iii, L.P. | 10% Owner | Sell | 320,000 | $22.00 | $7,040,000.00 | -12.6% | |
| Jun 15, 2015 | Warden Charles M | Director, 10% Owner | Sell | 320,000 | $22.00 | $7,040,000.00 | -12.6% | |
| Jun 10, 2015 | Versant Venture Capital Iii, L.P. | 10% Owner | Sell | 427,000 | $22.00 | $9,394,000.00 | -14.4% | |
| Jun 10, 2015 | Warden Charles M | Director, 10% Owner | Sell | 427,000 | $22.00 | $9,394,000.00 | -14.4% | |
| Jun 10, 2015 | Svlsf Iv, LLC | 10% Owner | Sell | 1,119,000 | $22.00 | $24,618,000.00 | -14.4% | |
| Feb 2, 2015 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Sell | 500,000 | $29.50 | $14,750,000.00 | -19.8% |